Robert N. Booher

2.5k total citations · 1 hit paper
10 papers, 2.0k citations indexed

About

Robert N. Booher is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Robert N. Booher has authored 10 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Robert N. Booher's work include Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers) and DNA Repair Mechanisms (3 papers). Robert N. Booher is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers) and DNA Repair Mechanisms (3 papers). Robert N. Booher collaborates with scholars based in United States and United Kingdom. Robert N. Booher's co-authors include Marc W. Kirschner, Jean Gautier, J. Fernando Bazán, Ali Fattaey, Raymond J. Deshaies, Caroline E. Alfa, David Beach, Jeremy S. Hyams, Wilbur R. Leopold and Yuli Wang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Robert N. Booher

10 papers receiving 1.9k citations

Hit Papers

cdc25 is a specific tyrosine phosphatase that directly ac... 1991 2026 2002 2014 1991 250 500 750

Peers

Robert N. Booher
Thimo Kurz United Kingdom
Taesaeng Choi South Korea
Tina H. Lee United States
Zu-Wen Sun United States
Thimo Kurz United Kingdom
Robert N. Booher
Citations per year, relative to Robert N. Booher Robert N. Booher (= 1×) peers Thimo Kurz

Countries citing papers authored by Robert N. Booher

Since Specialization
Citations

This map shows the geographic impact of Robert N. Booher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert N. Booher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert N. Booher more than expected).

Fields of papers citing papers by Robert N. Booher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert N. Booher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert N. Booher. The network helps show where Robert N. Booher may publish in the future.

Co-authorship network of co-authors of Robert N. Booher

This figure shows the co-authorship network connecting the top 25 collaborators of Robert N. Booher. A scholar is included among the top collaborators of Robert N. Booher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert N. Booher. Robert N. Booher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Booher, Robert N., Grzegorz S. Nowakowski, Krish Patel, et al.. (2018). Preclinical Activity of IRAK4 Kinase Inhibitor CA-4948 Alone or in Combination with Targeted Therapies and Preliminary Phase 1 Clinical Results in Non-Hodgkin Lymphoma. Blood. 132(Supplement 1). 4168–4168. 7 indexed citations
2.
Booher, Robert N., Maria Samson, Guang-Xin Xu, Hongsheng Cheng, & David Tuck. (2017). Abstract 1168: Efficacy of the IRAK4 inhibitor CA-4948 in patient-derived xenograft models of diffuse large B cell lymphoma. Cancer Research. 77(13_Supplement). 1168–1168. 8 indexed citations
3.
Choudhary, Gaurav S., Tushar D. Bhagat, Maria Samson, et al.. (2017). Abstract 127: Efficacy of novel IRAK4 inhibitor CA4948 in AML and MDS. Cancer Research. 77(13_Supplement). 127–127. 3 indexed citations
4.
Bian, Feng, Rathna Nath, Robert N. Booher, et al.. (2002). Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25‐transgenic mice. The Journal of Comparative Neurology. 446(3). 257–266. 80 indexed citations
5.
Wang, Yuli, Jun Li, Robert N. Booher, et al.. (2001). Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.. PubMed. 61(22). 8211–7. 173 indexed citations
6.
Booher, Robert N., et al.. (1997). Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity. Journal of Biological Chemistry. 272(35). 22300–22306. 232 indexed citations
7.
Fattaey, Ali & Robert N. Booher. (1997). Myt1: a Wee1-type kinase that phosphorylates Cdc2 on residue Thr14. PubMed. 3. 233–240. 61 indexed citations
8.
Booher, Robert N., Raymond J. Deshaies, & Marc W. Kirschner. (1993). Properties of Saccharomyces cerevisiae wee1 and its differential regulation of p34CDC28 in response to G1 and G2 cyclins.. The EMBO Journal. 12(9). 3417–3426. 294 indexed citations
9.
Gautier, Jean, et al.. (1991). cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell. 67(1). 197–211. 755 indexed citations breakdown →
10.
Booher, Robert N., Caroline E. Alfa, Jeremy S. Hyams, & David Beach. (1989). The fission yeast cdc2/cdc13/suc1 protein kinase: Regulation of catalytic activity and nuclear localization. Cell. 58(3). 485–497. 353 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026